NCT05278104 - A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

October 23, 2024

Study Completion Date

October 30, 2024

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Zentiva®

DRUG

Placebo

Trial Locations (5)

Universitätsklinikum Aachen, AöR, Aachen

Universitätsklinikum Bonn AöR, Bonn

Rheinhessen-Fachklinik Alzey, Alzey

Universitätsklinikum Frankfurt, Frankfurt

Universitätsklinikum Leipzig, Leipzig